triumph-3 retatrutide The numbers from Lilly's Phase 3 trial dropped this week and I haven't been able to stop thinking about them. Not only as a doctor but as a long-term GLP-1 user Lilly Prepares for Retatrutide FDA

doi:10.1038/s41386-022-01295-4CrossRefGoogle ScholarPubMed Realmuto, GM, August, GJ, Garfinkel, BD

Mechanisms of Action What makes BPC-157 so unique is its multi-faceted mechanisms of action

In Phase 2 clinical trials, participants achieved an average weight reduction of up to 24.2% of their body weight over 48 weeks - a result that is higher than the weight loss rate achieved with other injectable weight loss treatments in comparable studies

Why Mental Health Side Effects Are Under Scrutiny The focus on mental health side effects of GLP-1 medications comes from their action in the brain

Zero physical downtime

There's no required minimum or maximumwe adjust based on your progress and goals